Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials 33
Prominent Drugs 35
Clinical Trial Profile Snapshots 36
Appendix 141
Abbreviations 141
Definitions 141
Research Methodology 142
Secondary Research 142
About GlobalData 142
Contact Us 143
Source 143

List of Tables
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, G7 Countries (%), 2018* 17
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E7 Countries (%), 2018* 21
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Phase, 2018* 24
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 25
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 30
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35

List of Figures
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15
Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, G7 Countries (%), 2018* 16
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E7 Countries (%), 2018* 20
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 24
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 25
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 28
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 29
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 30
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 35
GlobalData Methodology 142

Companies Mentioned
- Novartis AG
- AstraZeneca Plc
- Aspen Pharmacare Holdings Ltd
- Mylan NV
- Astorg Partners
- Insud Pharma
- Dr. Reddy's Laboratories Ltd
- Krka dd Novo Mesto
- Jubilant Life Sciences Ltd
- Bluefish Pharmaceuticals AB